Pharma

Your Article Summary

See Latest Articles

MediGene to be Listed on TecDAX Index
MediGene, 02/06/09

The biotech company MediGene AG has been selected for inclusion on the TecDAX, an index of the Frankfurt Stock Exchange including Germany’s most important mid-cap technology companies. The TecDAX follows the blue chip DAX index and comprises 30 companies admitted to the stock market "Prime Standard" segment. In addition to compliance with comprehensive international transparency requirements, the admission criteria include an above-average market capitalization, and a high trading volume. According to the decision made by the German Stock Exchange on February 2009, MediGene has fulfilled the admission criteria for the TecDAX and will be included there as of February 2009.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

What Makes a Generic Medication Generic?
Journal of Psychosocial Nursing and Mental Health Services, 12/18/09

Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

 See all of Biotechnology

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09

ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09

CCHIT Appoints Officers
HealthDataManagement, 12/18/09

 See all of Research & Development